Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01526902 · ClinicalTrials.gov registry record · NA
Proclear 1-D Multifocal Nondispensing Study
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT01526902 is a NA study that has completed, run by CooperVision. The registered enrollment target is 49 participants.
The verdict
NCT01526902, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This study is designed to compare the relative performance related to subjective and objective vision between two multifocal soft contact lenses.
Interventions
- DEVICE omafilcon A / PC 1-D MF
- DEVICE lotrafilcon B / Air Optix MF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01526902
The ClinicalTrials.gov registry entry for NCT01526902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which omafilcon A / PC 1-D MF is the first listed.
NCT01526902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01526902 about?
NCT01526902 is a clinical study titled "Proclear 1-D Multifocal Nondispensing Study". This study is designed to compare the relative performance related to subjective and objective vision between two multifocal soft contact lenses.
What is the current status of trial NCT01526902?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2012-02. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01526902?
The interventions under investigation include: omafilcon A / PC 1-D MF (DEVICE), lotrafilcon B / Air Optix MF (DEVICE).
Who is sponsoring clinical trial NCT01526902?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.